Header Logo

Sheila Dowd

Concepts (78)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Phobia, Social
4
2023
13
0.730
 Why?
Cycloserine
5
2023
26
0.690
 Why?
Implosive Therapy
4
2023
19
0.590
 Why?
Transcranial Magnetic Stimulation
6
2015
17
0.400
 Why?
Depressive Disorder, Major
4
2015
99
0.340
 Why?
Antimetabolites
3
2019
12
0.320
 Why?
Clonazepam
3
2003
26
0.300
 Why?
Treatment Outcome
10
2023
3525
0.210
 Why?
Flunitrazepam
1
2002
1
0.200
 Why?
Substance Abuse Treatment Centers
1
2002
2
0.200
 Why?
GABA Modulators
1
2002
4
0.200
 Why?
Rape
1
2002
6
0.200
 Why?
Anti-Anxiety Agents
1
2002
38
0.200
 Why?
Antibiotics, Antitubercular
1
2020
2
0.170
 Why?
Antidepressive Agents
2
2015
97
0.140
 Why?
Adult
12
2021
7901
0.140
 Why?
Extinction, Psychological
3
2023
12
0.140
 Why?
Electroconvulsive Therapy
3
2007
16
0.130
 Why?
Double-Blind Method
4
2020
407
0.130
 Why?
Depressive Disorder, Treatment-Resistant
1
2015
10
0.120
 Why?
Panic Disorder
1
2016
134
0.120
 Why?
Humans
16
2023
27125
0.110
 Why?
Depressive Disorder
2
2007
175
0.110
 Why?
Combined Modality Therapy
3
2023
305
0.100
 Why?
Phobic Disorders
1
2013
66
0.100
 Why?
Behavior Therapy
1
2013
86
0.100
 Why?
Fear
2
2023
47
0.100
 Why?
Anxiety Disorders
2
2023
170
0.100
 Why?
Sleep Wake Disorders
1
2013
122
0.100
 Why?
Female
11
2020
15249
0.090
 Why?
Male
10
2020
14801
0.090
 Why?
Middle Aged
9
2016
9012
0.080
 Why?
Psychiatric Status Rating Scales
4
2013
309
0.070
 Why?
Placebos
2
2020
65
0.070
 Why?
Anticonvulsants
2
2007
56
0.070
 Why?
Attention
2
2003
124
0.060
 Why?
Severity of Illness Index
2
2020
892
0.050
 Why?
Substance Abuse Detection
1
2003
5
0.050
 Why?
Electric Stimulation
1
2003
50
0.050
 Why?
Forensic Medicine
1
2002
1
0.050
 Why?
Hair
1
2002
3
0.050
 Why?
Anxiety
1
2023
156
0.050
 Why?
Recurrence
2
2015
309
0.050
 Why?
Pilot Projects
2
2015
415
0.050
 Why?
Memory
1
2002
295
0.040
 Why?
Cognition Disorders
2
2007
986
0.040
 Why?
Drug Administration Schedule
1
2020
161
0.040
 Why?
Galvanic Skin Response
1
2019
7
0.040
 Why?
Placebo Effect
1
2019
12
0.040
 Why?
Photic Stimulation
1
2019
26
0.040
 Why?
Young Adult
2
2016
2022
0.040
 Why?
Mental Recall
1
2019
62
0.040
 Why?
Case-Control Studies
1
2020
589
0.040
 Why?
Prospective Studies
2
2015
1774
0.040
 Why?
Time Factors
2
2015
1438
0.030
 Why?
Retreatment
1
2015
8
0.030
 Why?
Watchful Waiting
1
2015
12
0.030
 Why?
Drug Resistance
1
2015
47
0.030
 Why?
Feasibility Studies
1
2015
214
0.030
 Why?
Gas Chromatography-Mass Spectrometry
2
2003
11
0.030
 Why?
Predictive Value of Tests
1
2013
478
0.020
 Why?
Comorbidity
1
2013
488
0.020
 Why?
Adolescent
2
2011
2177
0.020
 Why?
Kaplan-Meier Estimate
1
2010
177
0.020
 Why?
Aged
2
2015
9070
0.020
 Why?
Clinical Trials as Topic
1
2007
216
0.020
 Why?
Research Design
1
2007
186
0.020
 Why?
Follow-Up Studies
1
2010
1802
0.010
 Why?
Age Factors
1
2007
775
0.010
 Why?
Reference Standards
1
2003
23
0.010
 Why?
Calibration
1
2003
20
0.010
 Why?
Reaction Time
1
2003
102
0.010
 Why?
Memory, Short-Term
1
2003
96
0.010
 Why?
Electromagnetic Fields
1
2002
9
0.010
 Why?
Sensitivity and Specificity
1
2003
479
0.010
 Why?
Psychomotor Performance
1
2003
204
0.010
 Why?
Motor Activity
1
2003
321
0.010
 Why?
Neuropsychological Tests
1
2003
1197
0.010
 Why?
Dowd's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_